EDMONTON, Alberta, May 18 /PRNewswire/ -- Medical Services International Inc wishes to announce that as the mosquito season begins in different parts of the world; demand for the VScan diagnostic test kits that detect mosquito borne diseases is increasing. In particular, the demand is for VScan test kits that detect Malaria, Dengue Fever and West Nile.
Based on initial discussions with distributors, it appears that the Company will supply in excess of 800,000 VScan test kits that detect mosquito borne diseases during this mosquito season. The Company believes that the VScan test kits will perform so well this season that it will result in significant future sales exceeding several million kits per year. All of these kits have a gross value in excess of $2.25 US per kit.
About VScan
The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV 1&2, hepatitis B&C, Tuberculosis (TB), Dengue Fever, Malaria, West Nile, Syphilis and Prostate Cancer. The kits cannot be sold in Canada.
Medical Services International Inc trades in the United States on the NQB Pinksheets under the symbol “MSITF”. For further information, please contact Robert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com or http://www.minerva-biotech.com.
NOTE: Certain statements in this press release are “forward-looking statements” within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies
Medical Services International Inc
CONTACT: Robert Talbot of Medical Services International Inc,+1-780-430-6363
